Literature DB >> 28024405

Boosting Docking-Based Virtual Screening with Deep Learning.

Janaina Cruz Pereira1, Ernesto Raúl Caffarena1, Cicero Nogueira Dos Santos2.   

Abstract

In this work, we propose a deep learning approach to improve docking-based virtual screening. The deep neural network that is introduced, DeepVS, uses the output of a docking program and learns how to extract relevant features from basic data such as atom and residues types obtained from protein-ligand complexes. Our approach introduces the use of atom and amino acid embeddings and implements an effective way of creating distributed vector representations of protein-ligand complexes by modeling the compound as a set of atom contexts that is further processed by a convolutional layer. One of the main advantages of the proposed method is that it does not require feature engineering. We evaluate DeepVS on the Directory of Useful Decoys (DUD), using the output of two docking programs: Autodock Vina1.1.2 and Dock 6.6. Using a strict evaluation with leave-one-out cross-validation, DeepVS outperforms the docking programs, with regard to both AUC ROC and enrichment factor. Moreover, using the output of Autodock Vina1.1.2, DeepVS achieves an AUC ROC of 0.81, which, to the best of our knowledge, is the best AUC reported so far for virtual screening using the 40 receptors from the DUD.

Mesh:

Substances:

Year:  2016        PMID: 28024405     DOI: 10.1021/acs.jcim.6b00355

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  52 in total

1.  Data Set Augmentation Allows Deep Learning-Based Virtual Screening to Better Generalize to Unseen Target Classes and Highlight Important Binding Interactions.

Authors:  Jack Scantlebury; Nathan Brown; Frank Von Delft; Charlotte M Deane
Journal:  J Chem Inf Model       Date:  2020-08-04       Impact factor: 4.956

2.  The "OK, Molly" Chemistry.

Authors:  Yi Lu
Journal:  Acc Chem Res       Date:  2017-03-21       Impact factor: 22.384

Review 3.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

4.  DeepScreening: a deep learning-based screening web server for accelerating drug discovery.

Authors:  Zhihong Liu; Jiewen Du; Jiansong Fang; Yulong Yin; Guohuan Xu; Liwei Xie
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

5.  Ligand-Binding-Site Refinement to Generate Reliable Holo Protein Structure Conformations from Apo Structures.

Authors:  Hugo Guterres; Sang-Jun Park; Wei Jiang; Wonpil Im
Journal:  J Chem Inf Model       Date:  2020-12-18       Impact factor: 4.956

6.  Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening.

Authors:  Spencer S Ericksen; Haozhen Wu; Huikun Zhang; Lauren A Michael; Michael A Newton; F Michael Hoffmann; Scott A Wildman
Journal:  J Chem Inf Model       Date:  2017-07-12       Impact factor: 4.956

7.  Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations.

Authors:  Hugo Guterres; Wonpil Im
Journal:  J Chem Inf Model       Date:  2020-04-10       Impact factor: 4.956

Review 8.  Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.

Authors:  Yankang Jing; Yuemin Bian; Ziheng Hu; Lirong Wang; Xiang-Qun Xie
Journal:  AAPS J       Date:  2018-03-30       Impact factor: 4.009

9.  The NAD+-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications.

Authors:  Yahyah Aman; Johannes Frank; Sofie Hindkjær Lautrup; Adrian Matysek; Zhangming Niu; Guang Yang; Liu Shi; Linda H Bergersen; Jon Storm-Mathisen; Lene J Rasmussen; Vilhelm A Bohr; Hilde Nilsen; Evandro F Fang
Journal:  Mech Ageing Dev       Date:  2019-12-05       Impact factor: 5.432

10.  Estimating the Roles of Protonation and Electronic Polarization in Absolute Binding Affinity Simulations.

Authors:  Edward King; Ruxi Qi; Han Li; Ray Luo; Erick Aitchison
Journal:  J Chem Theory Comput       Date:  2021-03-25       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.